Lantheus Holdings Inc
NASDAQ:LNTH

Watchlist Manager
Lantheus Holdings Inc Logo
Lantheus Holdings Inc
NASDAQ:LNTH
Watchlist
Price: 60.88 USD -2.23%
Market Cap: 4B USD

Lantheus Holdings Inc
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Lantheus Holdings Inc
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Lantheus Holdings Inc
NASDAQ:LNTH
Cash from Operating Activities
$457.7m
CAGR 3-Years
34%
CAGR 5-Years
64%
CAGR 10-Years
56%
Haemonetics Corp
NYSE:HAE
Cash from Operating Activities
$289m
CAGR 3-Years
4%
CAGR 5-Years
12%
CAGR 10-Years
9%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Cash from Operating Activities
$221m
CAGR 3-Years
-28%
CAGR 5-Years
-20%
CAGR 10-Years
-9%
ICU Medical Inc
NASDAQ:ICUI
Cash from Operating Activities
$159.4m
CAGR 3-Years
93%
CAGR 5-Years
-4%
CAGR 10-Years
10%
Align Technology Inc
NASDAQ:ALGN
Cash from Operating Activities
$656m
CAGR 3-Years
-2%
CAGR 5-Years
6%
CAGR 10-Years
11%
Merit Medical Systems Inc
NASDAQ:MMSI
Cash from Operating Activities
$267.6m
CAGR 3-Years
27%
CAGR 5-Years
11%
CAGR 10-Years
13%
No Stocks Found

Lantheus Holdings Inc
Glance View

Lantheus Holdings Inc. is a captivating player in the healthcare sector, primarily operating within the niche of diagnostic medical imaging. The company's core mission revolves around enhancing diagnosis and treatment pathways, thus playing an integral role in patient care. At the heart of Lantheus's operations are its innovative diagnostic and therapeutic products, including radiopharmaceuticals and contrast agents that physicians rely on to obtain detailed images of the body's organs and tissues. Through a combination of proprietary technologies and strategic partnerships, Lantheus delivers solutions that help medical professionals make more informed clinical decisions, ultimately aiming to improve patient outcomes. This business generates revenue by developing, manufacturing, and commercializing its products, which are utilized across hospitals, clinics, and research centers worldwide. By consistently investing in research and development, Lantheus ensures a competitive edge through a robust pipeline of next-generation imaging agents. Strategic alliances and collaborative ventures further fortify its market presence, allowing the company to expand its reach and integrate new advancements into its product offerings. This commitment to innovation and collaboration has not only cemented its reputation in the life sciences industry but also ensures a steady and growing stream of income from its well-regarded product lines.

LNTH Intrinsic Value
HIDDEN
Show

See Also

What is Lantheus Holdings Inc's Cash from Operating Activities?
Cash from Operating Activities
457.7m USD

Based on the financial report for Sep 30, 2025, Lantheus Holdings Inc's Cash from Operating Activities amounts to 457.7m USD.

What is Lantheus Holdings Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
56%

Over the last year, the Cash from Operating Activities growth was -8%. The average annual Cash from Operating Activities growth rates for Lantheus Holdings Inc have been 34% over the past three years , 64% over the past five years , and 56% over the past ten years .

Back to Top